Correlation Between Aarey Drugs and Industrial Investment

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aarey Drugs and Industrial Investment at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aarey Drugs and Industrial Investment into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aarey Drugs Pharmaceuticals and Industrial Investment Trust, you can compare the effects of market volatilities on Aarey Drugs and Industrial Investment and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aarey Drugs with a short position of Industrial Investment. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aarey Drugs and Industrial Investment.

Diversification Opportunities for Aarey Drugs and Industrial Investment

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aarey and Industrial is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Aarey Drugs Pharmaceuticals and Industrial Investment Trust in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Industrial Investment and Aarey Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aarey Drugs Pharmaceuticals are associated (or correlated) with Industrial Investment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Industrial Investment has no effect on the direction of Aarey Drugs i.e., Aarey Drugs and Industrial Investment go up and down completely randomly.

Pair Corralation between Aarey Drugs and Industrial Investment

Assuming the 90 days trading horizon Aarey Drugs Pharmaceuticals is expected to under-perform the Industrial Investment. But the stock apears to be less risky and, when comparing its historical volatility, Aarey Drugs Pharmaceuticals is 1.04 times less risky than Industrial Investment. The stock trades about -0.04 of its potential returns per unit of risk. The Industrial Investment Trust is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest  34,170  in Industrial Investment Trust on September 2, 2024 and sell it today you would earn a total of  6,510  from holding Industrial Investment Trust or generate 19.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Aarey Drugs Pharmaceuticals  vs.  Industrial Investment Trust

 Performance 
       Timeline  
Aarey Drugs Pharmace 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aarey Drugs Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Industrial Investment 

Risk-Adjusted Performance

27 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Industrial Investment Trust are ranked lower than 27 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Industrial Investment unveiled solid returns over the last few months and may actually be approaching a breakup point.

Aarey Drugs and Industrial Investment Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aarey Drugs and Industrial Investment

The main advantage of trading using opposite Aarey Drugs and Industrial Investment positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aarey Drugs position performs unexpectedly, Industrial Investment can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Industrial Investment will offset losses from the drop in Industrial Investment's long position.
The idea behind Aarey Drugs Pharmaceuticals and Industrial Investment Trust pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Transaction History
View history of all your transactions and understand their impact on performance